GENOVIS: COMMUNIQUÉ FROM EXTRA GENERAL MEETING, JULY 21, 2011

The following decisions were adopted at the Extra General Meeting:

The Board shall consist of six ordinary members with no alternates until the next Annual General Meeting.

Nicklas Gerhardsson, Thomas Laurell, Carina Schmidt, Jacob Engellau and Ebba Åsly Fåhraeus were re-elected as Board members. Fredrik Lindgren has declined election and Kenth Petersson was elected new Board member. Ebba Åsly Fåhraeus was re-elected as Chairman of the Board.

Kenth Petersson (b 1956)

BA

Other board assignments: Chairman of the Board in AlphaBeta
AB, Biocrine AB, Spiber Technologies
AB and Science Pacific AB. Member of the Board in Alligator
Bioscience AB and BioInvent AB.

For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 46 10 12 35 sarah.fredriksson@genovis.com

Genovis develops and designs smart nanoparticles for preclinical imaging and diagnostics and also develops and sells tools for modification of antibodies.Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission ( 46 (0)31 745 50 00) is the Company’s certified adviser.